Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen

International Immunology

Volumn 10, Issue 4, 1998, Pages 463-472

  Lacabanne, Valérie ^a   Viguier, Mireille ^a   Romieu, Raphaëlle ^a   Kayibanda, Michèle ^a   Connan, Francine ^a   Sermet, Sandrine ^a   Antoine, Bénédicte ^a   Guillet, Jean Gérard ^a   Choppin, Jeannine ^a  

^a INSERM   (France)

Author keywords

Antigen presentation; MHC; Tumor antigen

Indexed keywords

EPITOPE; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOTHERAPY; KIDNEY CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS CELL TRANSFORMATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; H-2 ANTIGENS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031919085     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.4.463     Document Type: Article

References (40)

1. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
2. Robbins, P. F. and Kawakami, Y. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628.
3. Röpke, M., Hald, J., Guldberg, P., Zeuthens, J., Norgaard, L., Fugger, L., Svejgaard, A., Van der Bur, S., Nijman, H. W. and Melilef, C. J. M. 1996. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide, Proc. Natl Acad. Sci. USA 93:14704.
4. Gnjatic, S., Cai, Z., Viguier, M., Chouaib, S., Guillet, J.-G. and Choppin, J. 1998. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J. Immunol. 160:328.
5. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T. and Coulie, G. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
6. Harding, V. and Pfeifer, J. D. 1994. Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology 83:670.
7. Harris, P. E., Lupu, F., Hong, B., Reed, E. F. and Suciu-Foca, N. 1993. Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules. J. Exp. Med. 177:783.
8. Antoine B., Levrat, F., Vallet, V., Cartier, N., Dubois, N., Briand, P. and Kahn, A. 1992. Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. Exp. Cell Res. 200:175.
9. Levrat, F., Vallet, V., Berbar, T., Miquerol, L., Kahn, A. and Antoine B. 1993. Influence of the content in transcription factors on the phenotype of mouse hepatocyte-like cell lines (mhAT). Exp. Cell Res. 209:1.
10. Dubois, N., Bennoun, M., Allemand, I., Molina, T., Grimber, G., Daudet-Monsac, M., Abelanet, R. and Briand, P. 1991. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J. Hepatol. 13:227.
11. Lacabanne, V., Viguier, M., Guillet, J.-G. and Choppin, J. A. 1996. A wild-type p53 cytotoxic T cell epitope is presented by mouse hepatocarcinoma cells. Eur. J. Immunol. 26:2635.
12. Rouquet, N., Allemand, I., Molina, T., Bennoun, M., Briand, P. and Joulin, V. 1995. Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogene 11:1061.
13. Gooding, L. R. and O'Connell, K. A. 1983. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J. Immunol. 131:2580.
14. O'Connell, K. A. and Gooding, L. R. 1984. Cloned cytotoxic T lymphocytes recognize cells expressing discrete fragments of the SV40 tumor antigen. J. Immunol. 132:953.
15. Tevethia, S. S. 1990. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol. Biol. Med. 7:83.
16. + cytotoxic T lymphocytes in mice. Eur. J. Immunol. 22:759.
17. b-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. J. Virol. 66:440.
18. b-restricted determinant in simian virus 40 tumor antigen. Virology 208:159.
19. b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
20. b-restricted cytotoxic T-lymphocyte clones and a synthetic peptide. Virology 171:205.
21. Cartier, N., Miquerol, L., Tulliez, M., Lepetit, N., Levrat, F., Grimber, G., Briand, P. and Kahn, A. 1992. Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncogene 7:1413.
22. Rötzschke, O., Falf, K., Stevanovic, S., Jung, G., Walden, P. and Rammensee, H.-G. 1991. Exact prediction of a natural T cell epitope. Eur J. Immunol. 21:2891.
23. Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G. and Rammensee, H.-G. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
24. Milich, D., Hugues, J. L., McLachlan, A., Thornton, G. B. and Moriarty, A. 1988. Hepatitis B synthetic immunogen comprises of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl Acad. Sci. USA 85:1610.
25. Dahl, A. M., Beverly, P. C. and Stauss, H. J. 1996. A synthetic peptide derived from the tumor-associated protein mdm2 stimulates autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed protein. J. Immunol. 157:239.
26. Connan, F., Hlavac, F., Hoebeke, J., Guillet, J.-G. and Choppin, J. 1994. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur. J. Immunol. 24:777.
27. Do Ngoc Lien, D., Cesari, I. M., Bouty, I., Bout, D. and Hoebeke, J. 1992. Immunocapture assay for quantification of human IgA antibodies to parasite antigenic enzymes. J. Immunoassay 13:521.
28. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., del Guercio, M. F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M. and Chisari, F. V. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
29. Lynch, D. A. and Miller, R. E. 1994. Interleukin 7 promotes long-term in vitro growth of anti-tumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med. 179:31.
30. b-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J. Virol. 69:3134.
31. Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Ter Slchegget, J., Melief, C. J. M. and Kast, W. M. 1995. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicated human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25:2638.
32. Rotem-Yehudar, R., Winograd, S., Sela, S., Coligan, J. E. and Ehrlich, R. 1994. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus. J. Exp. Med. 180:477.
33. Schirmbeck, R. and Reimann, J. 1994. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur. J. Immunol 24:1478.
34. Tanaka, Y. and Tevethia, S. S. 1988. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J. Immunol. 140:4348.
35. Tanaka, Y. and Tevethia, S. S. 1990. Loss of immunorecessive cytotoxic T lymphocyte determinant V on SV40 T antigen following cocultivation with site-specific cytotoxic T lymphocytes clones. J. Immunol 140:4348.
36. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X.-F., Shimizu, J., Fujiwara, H. and Hamaoka, T. 1991. Transforming growth factor-beta-induced inhibition of T cell function. J. Immunol. 146:1077.
37. Romieu, R., Lacabanne, V., Kayibanda, M., Antoine, B., Bennoun, M., Chouaib, S., Guillet, J.-G. and Viguier, M. 1997. Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-α and transforming growth factor-β mRNA production. Int. Immunol. 9:1405.
38. Storkus, W. J., Zeh III, H. J., Maeurer, M. J., Salter, R. D. and Lotze, M. T. 1993. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J. Immunol. 151:3719.
39. Stevens, E. J., Jacknin, L., Robbins, P. F., Kawakami, Y., El Gamil, M., Rosenberg, S. and Yannelli, J. R. 1995. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J. Immunol. 154:762.
40. Toes, R. E. M., Schoenberger, S. P., van der Voort, E. I. J., Kast, W. M., Hoeben, R. C., Melief, C. J. M. and Offringa, R. 1997. Activation or frustration or anti-tumor responses by T-cell-based immune modulation. Semin. Immunol. 9:323.